Literature DB >> 17110199

High-throughput screening for modulators of stem cell differentiation.

Paul J Bushway1, Mark Mercola.   

Abstract

Realizing the potential of stem cell biology requires the modulation of self-renewal and differentiation, both of which are incompletely understood. This chapter describes methods for the design, development, and implementation of cell-based screens of small molecules, genes and expressed proteins for modulation of stem and progenitor cell fate. These include the engineering of embryonic and other stem cells with gene promoter-reporter protein constructs and their application in automated screening. We discuss considerations of promoter reporter selection, assay development and implementation, and image acquisition, analysis, and data handling. Such black-box screens are useful for the identification of probes of developmental processes and should provide tools that will identify druggable targets for biochemical assays.

Entities:  

Mesh:

Year:  2006        PMID: 17110199     DOI: 10.1016/S0076-6879(06)14017-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  12 in total

1.  Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation.

Authors:  Nathan Salomonis; Christopher R Schlieve; Laura Pereira; Christine Wahlquist; Alexandre Colas; Alexander C Zambon; Karen Vranizan; Matthew J Spindler; Alexander R Pico; Melissa S Cline; Tyson A Clark; Alan Williams; John E Blume; Eva Samal; Mark Mercola; Bradley J Merrill; Bruce R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

2.  1,5-Disubstituted benzimidazoles that direct cardiomyocyte differentiation from mouse embryonic stem cells.

Authors:  Karl J Okolotowicz; Paul Bushway; Marion Lanier; Cynthia Gilley; Mark Mercola; John R Cashman
Journal:  Bioorg Med Chem       Date:  2015-08-04       Impact factor: 3.641

Review 3.  A chemical biology approach to myocardial regeneration.

Authors:  Erik Willems; Marion Lanier; Elvira Forte; Frederick Lo; John Cashman; Mark Mercola
Journal:  J Cardiovasc Transl Res       Date:  2011-03-22       Impact factor: 4.132

4.  Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells.

Authors:  Robert Damoiseaux; Sean P Sherman; Jackelyn A Alva; Cory Peterson; April D Pyle
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

5.  Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesis.

Authors:  Alexandre R Colas; Wesley L McKeithan; Thomas J Cunningham; Paul J Bushway; Lana X Garmire; Gregg Duester; Shankar Subramaniam; Mark Mercola
Journal:  Genes Dev       Date:  2012-11-14       Impact factor: 11.361

6.  Serum-free generation of multipotent mesoderm (Kdr+) progenitor cells in mouse embryonic stem cells for functional genomics screening.

Authors:  Wesley L McKeithan; Alexandre R Colas; Paul J Bushway; Saugata Ray; Mark Mercola
Journal:  Curr Protoc Stem Cell Biol       Date:  2012-11

7.  A comparative analysis of standard microtiter plate reading versus imaging in cellular assays.

Authors:  Paul J Bushway; Mark Mercola; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2008-08       Impact factor: 1.738

8.  Natural and synthetic regulators of embryonic stem cell cardiogenesis.

Authors:  Erik Willems; Paul J Bushway; Mark Mercola
Journal:  Pediatr Cardiol       Date:  2009-03-25       Impact factor: 1.655

Review 9.  Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

Authors:  Bin-Bing S Zhou; Haiying Zhang; Marc Damelin; Kenneth G Geles; Justin C Grindley; Peter B Dirks
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

10.  Synthesis and SAR of b-annulated 1,4-dihydropyridines define cardiomyogenic compounds as novel inhibitors of TGFβ signaling.

Authors:  Dennis Schade; Marion Lanier; Erik Willems; Karl Okolotowicz; Paul Bushway; Christine Wahlquist; Cynthia Gilley; Mark Mercola; John R Cashman
Journal:  J Med Chem       Date:  2012-11-06       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.